Actuate Therapeutics, Inc.

NasdaqCM:ACTU Stock Report

Market Cap: US$172.5m

Actuate Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Dan Schmitt

Chief executive officer

US$520.0k

Total compensation

CEO salary percentage76.9%
CEO tenure9.3yrs
CEO ownership2.9%
Management average tenureno data
Board average tenure1.8yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Dan Schmitt's remuneration changed compared to Actuate Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$28m

Dec 31 2023US$520kUS$400k

-US$25m

Compensation vs Market: Dan's total compensation ($USD520.00K) is below average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Insufficient data to compare Dan's compensation with company performance.


CEO

Dan Schmitt (62 yo)

9.3yrs

Tenure

US$520,000

Compensation

Mr. Daniel M. Schmitt, also known as Dan, serves as Chief Executive Officer and President at Actuate Therapeutics, Inc. since March 2015. Mr. Schmitt served as Chief Operating Officer of Genus Oncology, LL...


Board Members

NamePositionTenureCompensationOwnership
Daniel Schmitt
CEO, President & Director9.3yrsUS$520.00k2.93%
$ 5.1m
Todd Thomson
Independent Director1.8yrsno datano data
John Marshall
Member of Scientific Advisory Board1.8yrsno datano data
Lee Ellis
Member of Scientific Advisory Board1.8yrsno datano data
Roger Cohen
Member of Scientific Advisory Board1.8yrsno datano data
Daniel Zabrowski
Independent Director3.3yrsno data0.40%
$ 693.4k
Leslie Kreis
Independent Director9.3yrsno data0.37%
$ 630.0k
Aaron Glenn Fletcher
Independent Chairman9.3yrsno data0.41%
$ 700.0k
Patricia LoRusso
Member of Scientific Advisory Board1.8yrsno datano data
Daniel Billadeau
Member of Scientific Advisory Boardno datano datano data

1.8yrs

Average Tenure

62yo

Average Age

Experienced Board: ACTU's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.